Message US
 Dennis Vermeulen

By Dennis Vermeulen | July 18, 2016 |

NFIA Industries LSH Brochure2016.FINAL WW

A Hub for Life Sciences & Health Innovation

Home to some 2,500 life sciences, medical technology companies and research organizations, the Netherlands has one of the most concentrated life science clusters in the world.

Life Science Leaders Choose Holland

Major multinationals like Merck (MSD), Amgen, Genmab, Astellas, GlaxoSmithKline and Medtronic choose the Netherlands for a multitude of operations, including R&D, headquarters, manufacturing and logistics. In fact, in the last three years, 17 major biotech deals involved Dutch companies.

Unmatched Business Advantages

Holland’s multilingual workforce, competitive tax support measures, pro-business climate and high-quality infrastructure for clinical research make it a strategic location for life sciences and health companies looking to expand in the European market.

Your Name (required)

Your Email (required)